Therapy of ventilator-associated pneumonia: What more can we do to use less antibiotics?

Critical Care Medicine

Volumn 32, Issue 11, 2004, Pages 2344-2345

  Niederman, Michael S ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Antibiotic therapy; De escalation; Duration of therapy; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ASPIRATION; BRONCHOSCOPY; EDITORIAL; HUMAN; MULTIDRUG RESISTANCE; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; VENTILATOR;

ANTI-BACTERIAL AGENTS; CRITICAL CARE; CROSS INFECTION; EMPIRICAL RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES; RESPIRATION, ARTIFICIAL; TIME FACTORS;

EID: 8544258106     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000146138.34857.7C     Document Type: Editorial

References (9)

1. Niederman MS: Appropriate use of antimicrobial agents: Challenges and strategies for improvement. Crit Care Mad 2003; 31:608-616
2. Hoffken G, Niederman MS: Nosocomial pneumonia: The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122:2183-2196
3. Rello J, Vidaur L, Sandiumenge A, et al: Deescalation therapy in ventilator-associated pneumonia. Crit Care Med 2004; 32: 2183-2190
4. Ibrahim EH, Ward S, Sherman G, et al: Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115
5. Micek ST, Ward S, Fraser VJ, et al: A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004; 125: 1791-1799
6. Luna CM, Blanzaco D, Niederman MS, et al: Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31:676-682
7. Dennesen PJ, Van der Ven AJ, Kessels AG, et al: Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001; 163:1371-1375
8. Chastre J, Wolff M, Fagon JY, et al: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003; 290:2588-2598
9. Paul M, Benuri-Silbiger I, Soares-Weiser K, et al: Beta-lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: Systematic review and meta-analysis of randomized trials. BMJ 2004; 328:668